ABL Bio
KOSDAQ:A298380
153.800,00
₩-600,00 (-0,39%)
153.800,00
₩-600,00 (-0,39%)
End-of-day quote: 04/07/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩-1.156,00
Earnings Per Share
₩691,86
Revenue Per Share
99,82%
Gross Margin %
₩8.644,46 B
Market Cap
₩43,00 B
Long-Term Debt
Earnings Per Share
₩-1.156,00
Revenue Per Share
₩691,86
Gross Margin %
99,82%
Market Cap
₩8.644,46 B
Long-Term Debt
₩43,00 B

Financials

Year Year 2024 2023 2022 2018
EPS Earnings Per Share ₩-1.156,00 ₩-55,00 ₩81,00 ₩-3.804,00
Earnings Earnings ₩-55,81B ₩-2,63B ₩3,87B ₩-0,00M
RPS Revenue Per Share ₩691,86 ₩1,37k ₩1,37k N/A
Revenue Revenue ₩33,40B ₩65,55B ₩65,33B ₩1,26B
OCF Operating Cash Flow ₩-69,40B ₩-28,36B ₩47,00B ₩0,00M
FCF Free Cash Flow ₩-78,43M ₩-28,37B ₩46,00B ₩0,00M
OM Operating Margin -177,76% -3,99% 1,35% 0,00%
GM % Gross Margin % 99,82% 99,93% 99,88% 91,63%
FCFS Free Cash Flow Per Share ₩-1.633,87 ₩-714,95 ₩1,47k ₩-453,81
LT Debt Long-Term Debt ₩43,00B ₩43,00B ₩40,00B N/A
Sha. Stocks 48,28M 47,89M 47,79M 44,59M
×